Alaunos Therapeutics, Inc. · NASDAQ:TCRT

Weis Holger received 23,564 Alaunos Therapeutics, Inc. shares as an award (Form 4)

Traded Oct 6, 2026 · Filed Oct 8, 2026

On Oct 6, 2026, Weis Holger (CEO) received 23,564 Alaunos Therapeutics, Inc. shares as an award at US$0.74 for US$17,541, leaving 49,047 shares. Filed Oct 8, 2026 (Form 4).

Awarded
23,564 shares
Price
US$0.74
Value
US$17,541
Holding after
49,047 shares
Trading plan
No
Role
CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 6, 2026Common StockAward23,564US$0.7449,047Direct

Source

View original at SEC

Related